ALFA Finder| Revenue growth | 43.5% YoY for Q4; 36.6% for FY26. |
|---|---|
| Margins | Operating EBITDA holding in 22-23% range despite higher outsourcing. |
| Demand visibility | Strong visibility for FY29/30 based on current R&D spend. |
| Management confidence | High; citing strong revenue visibility and R&D productivity trends. |
Growth
FY26 revenue reached ₹17,540M, a 36.6% increase YoY. PAT surged 83.6% to ₹2,467M with EBITDA margins improving to 23.3%.
Outlook
Guided ₹5,000M+ R&D spend over 9 quarters; Pithampur site production ramp-up expected in Q1 CY27 to be margin accretive.
Risks
Reliance on outsourced manufacturing due to internal capacity constraints has slightly contracted sequential gross margins from 66.5% to 66.3%.
Earnings Call filed with BSE, NSE: RUBICON. Summary written with AI assistance from the document.
Rubicon Research Ltd: key numbers
- Share price
- ₹1,734.00
- Market cap
- ₹28,703 Cr
- Revenue (annual)
- ₹1,754 Cr
- Net profit (annual)
- ₹246.7 Cr
- P/E (TTM)
- 88.4×Sector 43.8×
- Promoter holding
- 51.25%-8.51% QoQ
- FII holding
- 9.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rubicon Research Ltd
All →Rubicon Research Earnings Call Transcript: Key Takeaways
Q2 revenue rose 40% to ₹576 Cr with 25% operating EBITDA margin and ₹90 Cr PAT. Arena acquisition flatters growth, and recent plant inspections remain unresolved.
Rubicon Research Other Announcement
Rubicon Research filed the India Ratings monitoring agency report for the IPO fresh issue proceeds for the quarter ended September 30, 2026. The agency found no deviation from the stated objects of the issue.
Rubicon Research Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹5,764Mn (+39.9%), EBITDA ₹1,464Mn (+54.1%, 25.4% margin), PAT ₹904Mn (+67.9%). Arinna consolidated; FY27 margin guidance raised to 24%+.
Rubicon Research Q2 FY27 Results: Net Profit ₹90.4 Cr, Up 67.7% YoY
Rubicon Research Ltd reported revenue from operations of ₹576.4 Cr (+39.9% YoY) and net profit of ₹90.4 Cr (+67.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹90.4 Cr · +67.7% YoY
Rubicon Research Employee Stock Options
Rubicon Research Limited granted 68,982 stock options at an exercise price of Rs. 1,374.40 per share. The options vest over five years under the company's 2026 ESOP plan.
Rubicon Research Business Update
Rubicon Research disclosed a USFDA inspection of its Ambernath facility, which issued five procedural Form 483 observations. No monetary penalty or amount is involved.